LOURDES LABRADA: Open Payments
NPI 1215166269 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,661 in 42 payments from 15 companies in 2025. Trend: 2023 $944 · 2024 $1,198 · 2025 $1,661
Food & beverage: $1,661
| Company | Payments | Amount |
|---|---|---|
| Cleerly, Inc. | 3 | $420 |
| Kestra Medical Technology Services, Inc. | 2 | $220 |
| Novo Nordisk Inc | 7 | $192 |
| BridgeBio Pharma, Inc. | 6 | $155 |
| Abbott Laboratories | 4 | $120 |
| E.R. Squibb & Sons, L.L.C. | 5 | $109 |
| Medtronic, Inc. | 1 | $101 |
| Actelion Pharmaceuticals US, Inc. | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $56 |
| Boston Scientific Corporation | 2 | $53 |
Products named: Cleerly Ischemia, Assure WCD, Attruby, COREVALVE EVOLUT R, CAMZYOS, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, UPTRAVI, WATCHMAN FLX.
Industry payments across FL — which companies pay providers there.
